FIELD: medicine, oncology. SUBSTANCE: tumor is subjected to effects of alternating electromagnetic field. Electromagnetic field inside human body is generated by dipole radiator not more than 50 mm long, which issues modulated electric signal with amplitude of not more than 100 mA, at frequencies from 4 Hz to 40 MHz, and with constant amplitude component from 0 to 1 mA. Treatment with electromagnetic field can be carried out both against background of administration of antitumoral medicinal preparations, and in their absence. EFFECT: method can be used for treatment and prophylaxis of malignant growths, for preventing metastatic propagation, and for reducing dosages of cytostatic preparations administered. 2 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD TO CORRECT IMMUNITY PARAMETERS | 1996 |
|
RU2081636C1 |
POLYPEPTIDE DISPLAYING ANALOG OF RECEPTOR-BINDING EPIDERMAL GROWTH FACTOR FRAGMENT FROM 21 TO 31 AMINO ACIDS, ITS CONJUGATE WITH DOXORUBICIN AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2001 |
|
RU2196604C1 |
METHOD FOR ASSESSING INDIVIDUAL CHEMOSENSITIVITY OF TUMORS IN PATIENTS | 1992 |
|
RU2068563C1 |
MEANS STIMULATING CHEMOPREPARATION ANTI-TUMOR ACTIVITY AND METHOD FOR TREATING ONCOLOGICAL DISEASES | 2002 |
|
RU2250775C2 |
ANTI-TUMOUR AGENT | 2013 |
|
RU2541130C1 |
METHOD OF LIPID METABOLISM MODIFICATION | 1996 |
|
RU2071379C1 |
METHOD OF SELECTION OF MEDICINAL PREPARATIONS FOR CORRECTION OF DISTURBANCES OF IMMUNOLOGICAL STATUS IN TUMOR DISEASE | 1992 |
|
RU2140081C1 |
IMMUNOMODULATING AGENT AND A PHARMACEUTICAL COMPOSITION EXHIBITING ANTITUMOR ACTIVITY | 1997 |
|
RU2121363C1 |
METHOD OF NON-HODGKIN'S LYMPHOMAS TREATMENT | 2000 |
|
RU2180594C1 |
ANTITUMOR PEPTIDE PREPARATION BASED ON ALPHA-FETOPROTEIN FRAGMENT, ITS CONJUGATE, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF HORMONE-DEPENDENT TUMORS | 2005 |
|
RU2285537C1 |
Authors
Dates
1997-01-10—Published
1996-01-30—Filed